Market Overview
The European intraocular lens market represents a critical segment of the broader ophthalmology sector, which is projected to grow from $13.3 billion to $18.9 billion by 2030. Intraocular lenses themselves command significant market share, representing approximately 45% of the global cataract surgery devices market. The European eye care market, encompassing IOLs, contact lenses, and ocular health products, is valued at approximately $7.36 billion and expected to reach $9.62 billion by 2033.
- •European ophthalmology market projected at $13.3 billion in 2025, growing at 7.3% CAGR to $18.9 billion by 2030
- •Intraocular lenses account for approximately 45% share of the global cataract surgery devices market
- •The broader European eye care segment reached $7.36 billion in 2025
Growth Drivers
An aging European population is the primary catalyst, as cataract prevalence rises sharply after age 60 and surgical intervention becomes the standard treatment. Increasing patient preference for premium toric, multifocal, and extended depth of focus lenses that provide spectacle independence is expanding average selling prices. Rising healthcare expenditure and improved reimbursement frameworks across EU member states are enabling higher surgical volumes and faster adoption of advanced IOL technologies.
- •Demographic shift toward older age groups driving higher cataract surgery rates across Europe
- •Growing demand for premium toric, multifocal, and EDOF lenses that reduce dependence on glasses
- •Expanded healthcare coverage and reimbursement supporting increased surgical adoption
Segmentation and Regional Analysis
The market is segmented primarily by lens type, including monofocal, multifocal, toric, and extended depth of focus varieties, with monofocal lenses historically representing the largest revenue share at over 54%. Western Europe, particularly Germany, France, and the UK, dominates current market value due to higher surgical rates and premium product adoption. Eastern European markets are emerging as the fastest-growing segment as healthcare infrastructure improves and cataract surgery access expands.
- •Monofocal intraocular lenses account for over 54% of global market revenue
- •Germany, France, and the UK lead Western European market share
- •Eastern Europe represents the highest growth opportunity due to expanding surgical access
Trends and Outlook
What are the recent trends and outlook?
The market is trending toward expanded adoption of premium lens technologies, particularly toric IOLs for astigmatism correction and multifocal or EDOF designs that deliver spectacle-free vision across multiple distances. Integration of digital platforms and AI-assisted surgical planning tools is enhancing procedural precision and patient outcomes. The market is expected to maintain robust growth through the early 2030s as aging demographics, technological advancement, and rising healthcare investment converge across the European region.
- •Accelerating shift toward premium toric, multifocal, and extended depth of focus lens adoption
- •Integration of AI and digital tools improving surgical outcomes and patient selection
- •Market projected to sustain mid-to-high single-digit growth through 2030s
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.